Alexeev et al. The Crystal Structure of 8-Amino-7-oxononanoate Synthase: A Bacterial PLP-dependent, Acyl-CoA-condensing Enzyme. Journal of Molecular Biology,. Nov. 1998, vol. 284, No. 2, pp. 401-419.* |
Fraser et al. Phosphorylated and Dephosphorylated Structures of Pig Heart, GTP-specific Succinyl-CoA Synthetase. Journal of Molecular Biology. Jun. 2000, vol. 299, No. 5, pp. 1325-1339.* |
Barker et al., “Conserved cysteine and histidine residues in the structures of the tyrosyl and methionyl-tRNA synthetases”, FEBS Letters, vol. 145, No. 2, Aug. 1982, pp. 191-193. |
Bohacek et al., “The Art and Practice of Structure-Based Drug Design: A Molecular Modeling Perspective”, Medicinal Research Reviews, vol. 16, (1996), pp. 3-50. |
Brick et al., “Structure of Tyrosyl-tRNA Synthetase Refined at 2-3, A Resolution”, J. Med. Biol. (1988), 208, pp. 83-98. |
Greer et al., “Application of the Three-Dimensional Structures of Protein Target Molecules in Structure-Based Drug Design”, Journal of Medicinal Chemistry, Apr. 15, 1994, vol. 37, No. 8, pp. 1035-1054. |
Izard et al., “The crystal structure of a novel bacterial adenylyltransferase reveals half of sites reactivity”, The EMBO Journal, vol. 18, No. 8, (1999), pp. 2021-2030. |
Jones et al., “Docking small-molecule ligands into active sites”, Current Opinion in Biotechnology, vol. 6, (1995), pp. 652-656. |
Mechulam et al., “Crystal Structure of Escherichia coli Methionyl-tRNA synthetase Highlights Species-specific Features”, J. Mol. Biol., (1999), 294, pp. 1287-1297. |
Nureki et al., “Architectures of Class-Defining and Specific Domains of Glutamyl-tRNA Synthetase”, Science, vol. 267, Mar. 31, 1995, p. 1958-1965. |
Perona et al., “Structural Basis for Transfer RNA Aminoacylation of Escherichia coli Glutaminyl-tRNA Synthetase”, Biochemistry, 1993, 32, pp. 8758-8771. |
Shuker et al., “Discovering High-Affinity Ligands for Proteins: SAR by NMR”, Science, vol. 274, Nov. 29, 1996, pp. 1531-1534. |
Stout et al., “The additivity of substrate fragments in enzyme-ligand binding”, Structure, 6, (1998), pp. 839-848 (Research Article). |
Van Duyne et al., “Atomic Structures of the Human Immunophilin FKBP-12 Complexes with FK506 and Rapamycin”, J. Mol. Biol. (1993), 229, pp. 105-124. |
Verlinde et al., “In search of new lead compounds for trypanosomiasis drug design: A protein structure-based linked-fragment approach”, Journal of Computer Aided Molecular Design, 6, (1992), pp. 131-147. |
Weber et al., “A prototypical cytidylyltransferase: CTP:glycerol-3-phosphate cytidylyltransferase from Bacillus subtilis”, Structure with Folding and Design, 7, (1999), pp. 1113-1124. |
Delft et al, “The crystal structure of E. coli pantothenate synthetase confirms it as a member of the cytidylytransferase superfamily,” Structure, vol. 9, May 2001, pp. 439-450; XP002187263. |
Qoronfleh et al, “Production of selenomethionine-labeled recombinant . . . ”, Journal of Biotechnology Elsevier Science Publishers, Amsterdam, NL, vol. 39, No. 2, Apr. 15, 1995, pp. 119-128; XP004036977. |
Shao et al, “Accessibility of selenomethionine . . . ”, FEBS Letters, Elsevier Science Publishers, Amsterdam, NL, vol. 441, No. 1, Dec. 11, 1998, pp. 77-82; XP004258875. |
Jhoti, “High-throughput structural . . . ”, Trends in Biology, Elsevier Publications, Cambridge, GB, vol. 19, No. 10, Oct. 1, 2001, pp. S67-S71; XP004310381. |